The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/1534735421991218 |
_version_ | 1819061840683991040 |
---|---|
author | Geliang Yang MD, PhD Min Li MD Huiqing Zhang MD, PhD Yufei Yang MD, PhD |
author_facet | Geliang Yang MD, PhD Min Li MD Huiqing Zhang MD, PhD Yufei Yang MD, PhD |
author_sort | Geliang Yang MD, PhD |
collection | DOAJ |
first_indexed | 2024-12-21T14:49:17Z |
format | Article |
id | doaj.art-47ec07297eff4052bd1160a75883927b |
institution | Directory Open Access Journal |
issn | 1534-7354 1552-695X |
language | English |
last_indexed | 2024-12-21T14:49:17Z |
publishDate | 2021-02-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Integrative Cancer Therapies |
spelling | doaj.art-47ec07297eff4052bd1160a75883927b2022-12-21T18:59:55ZengSAGE PublishingIntegrative Cancer Therapies1534-73541552-695X2021-02-012010.1177/1534735421991218The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic WorldwideGeliang Yang MD, PhD0Min Li MD1Huiqing Zhang MD, PhD2Yufei Yang MD, PhD3Department of Traditional Chinese Medicine, the Second Medical Center, Chinese PLA General Hospital, Beijing, ChinaDepartment of Medicine, Shanghai Clinical Research Center, Shanghai, ChinaDepartment of Traditional Chinese Medicine, Naval Medical University, Shanghai, ChinaDepartment of Oncology Diagnosis and Treatment, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Chinahttps://doi.org/10.1177/1534735421991218 |
spellingShingle | Geliang Yang MD, PhD Min Li MD Huiqing Zhang MD, PhD Yufei Yang MD, PhD The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide Integrative Cancer Therapies |
title | The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide |
title_full | The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide |
title_fullStr | The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide |
title_full_unstemmed | The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide |
title_short | The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide |
title_sort | challenge and management of clinical trials in integrative cancer during the covid 19 pandemic worldwide |
url | https://doi.org/10.1177/1534735421991218 |
work_keys_str_mv | AT geliangyangmdphd thechallengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT minlimd thechallengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT huiqingzhangmdphd thechallengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT yufeiyangmdphd thechallengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT geliangyangmdphd challengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT minlimd challengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT huiqingzhangmdphd challengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT yufeiyangmdphd challengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide |